“…Up to now, some inorganic and organic materials including iron oxide, silicon dioxide, ferritin, albumin, chitosan, oligosaccharides, cyclodextrin (CD), PAMAM dendrimers, poly (lactide-co-glycolide) (PLGA), poly(alkyl cyanoacrylate) (PACA), d-α-tocopheryl polyethylene glycol 1000-block-poly (β-amino ester) (TPGS-PAE), and monomethoxy poly(ethylene glycol)-poly(lactide) copolymers (MPEG-PLAs) have been used to fabricate curcumin nanoformulations ( Acharya and Sahoo, 2011 ; Cui et al, 2013 ; Dilnawaz and Sahoo, 2013 ; Mollazade et al, 2013 ; Chen et al, 2014 ; Fang et al, 2014 ; Lou et al, 2014 ; Sankar et al, 2014 ; Poorghorban et al, 2015 ; Scarano et al, 2015 ; Wang et al, 2015 ; Chen et al, 2016 ; de Oliveira et al, 2016 ; Ndong Ntoutoume et al, 2016 ; Pawar et al, 2016b ; Zheng et al, 2016 ; Zhang et al, 2017 ; Yadav et al, 2018 ). These as-prepared curcumin nanoformulations have been proven to have enhanced anticancer efficacy as well as significant improvement in bioavailability and retention time ( Pramanik et al, 2012 ; Zheng et al, 2016 ; Falconieri et al, 2017 ; Thulasidasan et al, 2017 ). Zhang et al (2017) reported that a nanoparticle containing curcumin and DOX enhanced anticancer efficacy of DOX and reduced its systematic toxicity.…”